September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Raffaele Colombo: New BLA submitted for patients with EGFR-m NSCLC
Nov 13, 2024, 23:35

Raffaele Colombo: New BLA submitted for patients with EGFR-m NSCLC

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared an article on X:

“Dato-DXd previous BLA (based on TROPION-Lung01) voluntary withdrew and new BLA (based on TROPION-Lung05) submitted for patients with EGFR-m NSCLC!!”

Raffaele Colombo

Raffaele Colombo, a leading figure in the pharmaceutical industry is the Associate Director of Medicinal Chemistry at Zymeworks Inc.. His leadership and scientific acumen drive the discovery and optimization of novel drug candidates and advancing the treatment landscape for various diseases.